Fichero a descargar de la publicaciÃ³n mostrada - Sociedad ...

More documents

Recommendations

Info

Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 56______________________________________________________________________________261. Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with anadjunctive antibiotic lock solution. Kidney Int 2002; 61:1136-42.262. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P. Treatment of haemodialysis catheter-relatedinfections. Nephrol Dial Transplant 2002; 17:1149-50.263. Rao JS, O'Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection.J Hosp Infect 1992; 22:109-16.264. Piketty C, Hoi AB, Gilquin J, et al. Failure of antibiotic therapy in Staphylococcus epidermidis infection ofimplantable venous access devices in patients with AIDS, as documented by molecular typing. Clin MicrobiolInfect 1999; 5:190-4.265. Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous access port-related bacteremia inpatients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool.Clin Infect Dis 2001; 32:1776-83.266. De SL, Jenkner A, Milano GM, et al. Antibiotic lock with vancomycin and urokinase can successfully treatcolonized central venous catheters in pediatric cancer patients. Pediatr Infect Dis J 2004; 23:963-5.267. Bernardi M, Cavaliere M, Cesaro S. [The antibiotic-lock therapy in oncoematology pediatric unit]. AssistInferm Ric 2005; 24:127-31.268. Sánchez-Muñoz A, Aguado JM, López-Martín A, et al. Usefulness of antibiotic-lock technique inmanagement of oncology patients with uncomplicated bacteremia related to tunneled catheters. Eur J ClinMicrobiol Infect Dis 2005; 24:291-3.269. Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infectionswith the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J 1994; 13:930-1.270. Krzywda EA, Andris DA, Edmiston CE Jr., Quebbeman EJ. Treatment of Hickman catheter sepsis usingantibiotic lock technique. Infect Control Hosp Epidemiol 1995; 16:596-8.271. Viale P, Pagani L, Petrosillo N, et al. Antibiotic lock-technique for the treatment of catheter-relatedbloodstream infections. J Chemother 2003; 15:152-6.272. Del Pozo JL, García CM, Hernáez S, et al. Effectiveness of teicoplanin versus vancomycin lock therapy in thetreatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. Int JAntimicrob Agents 2009; 34:482-5.273. Diamanti A, Basso MS, Castro M, Calce A, Gambarara M. Antibiotic-lock therapy in central venous cathetercolonization in patients with intestinal failure. J Infect 2007; 54:415-6.274. Fernández-Hidalgo N, Almirante B, Calleja R, et al. Antibiotic-lock therapy for long-term intravascularcatheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother 2006;57:1172-80.275. Cercenado E. [Staphylococcus lugdunensis: a unique coagulase-negative Staphylococcus]. Enferm InfeccMicrobiol Clin 2009; 27:139-42.276. Onder AM, Chandar J, Billings AA, et al. Comparison of early versus late use of antibiotic locks in thetreatment of catheter-related bacteremia. Clin J Am Soc Nephrol 2008; 3:1048-56.277. Del Pozo JL, Alonso M, Serrera A, Hernáez S, Aguinaga A, Leiva J. Effectiveness of the antibiotic locktherapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstreaminfections. Diagn Microbiol Infect Dis 2009; 63:208-12.278. Peterson WJ, Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Enterococcusbacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 2009; 53:107-11.
Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 57______________________________________________________________________________279. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidencebasedreview. Clin Infect Dis 2002; 34:591-9.280. Pasqualotto AC, Severo LC. The importance of central venous catheter removal in patients with candidaemia:time to rethink our practice? Clin Microbiol Infect 2008; 14:2-4.281. Viale P, Petrosillo N, Signorini L, Puoti M, Carosi G. Should lock therapy always be avoided for centralvenous catheter-associated fungal bloodstream infections? Clin Infect Dis 2001; 33:1947-8.282. Castagnola E, Marazzi MG, Tacchella A, Giacchino R. Broviac catheter-related candidemia. Pediatr InfectDis J 2005; 24:747.283. Angel-Moreno A, Boronat M, Bolaños M, Carrillo A, González S, Pérez Arellano JL. Candida glabratafungemia cured by antibiotic-lock therapy: case report and short review. J Infect 2005; 51:e85-7.284. Buckler BS, Sams RN, Goei VL, et al. Treatment of central venous catheter fungal infection using liposomalamphotericin-B lock therapy. Pediatr Infect Dis J 2008; 27:762-4.285. Megged O, Shalit I, Yaniv I, Fisher S, Livni G, Levy I. Outcome of antibiotic lock technique for persistentcentral venous catheter-associated coagulase-negative Staphylococcus bacteremia in children. Eur J ClinMicrobiol Infect Dis 2010; 29:157-61.286. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Incidence of bloodstream infection inmulticenter inception cohorts of hemodialysis patients. Am J Infect Control 2004; 32:155-60.287. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factorsfor bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9:869-76.288. Hill EE, Vanderschueren S, Verhaegen J, et al. Risk factors for infective endocarditis and outcome of patientswith Staphylococcus aureus bacteremia. Mayo Clin Proc 2007; 82:1165-9.289. Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Staphylococcus aureusbacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 2007; 50:289-95.290. Sociedad Española de Qumioterapia, Asociación Española de Hematología y Hemoterapia, Sociedad Españolade Oncología Médica, Sociedad Española de Medicina Interna. Tratamiento de las infecciones relacionadas concatéteres venosos de larga duración. Rev Esp Quimioter 2003; 16:343-60.291. Anthony TU, Rubin LG. Stability of antibiotics used for antibiotic-lock treatment of infections of implantablevenous devices (ports). Antimicrob Agents Chemother 1999; 43:2074-6.292. Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: in vitroantibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 2000; 20:394-9.293. Droste JC, Jeraj HA, MacDonald A, Farrington K. Stability and in vitro efficacy of antibiotic-heparin locksolutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother2003; 51:849-55.294. Bastani B, Amin K, Herr A. Prolonged stability of stored vancomycin, gentamicin, and heparin for use in theantibiotic-lock technique. ASAIO J 2005; 51:761-3.295. Battistella M, Walker S, Law S, Lok C. Antibiotic lock: in vitro stability of vancomycin and four percentsodium citrate stored in dialysis catheters at 37 degrees C. Hemodial Int 2009; 13:322-8.296. Soriano A, Bregada E, Marques JM, et al. Decreasing gradient of antibiotic concentration in the lumen ofcatheters locked with vancomycin. Eur J Clin Microbiol Infect Dis 2007; 26:659-61.297. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infectionsusing catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol2002; 13:2133-9.
Page 1 and 2:
AVANCES ENENFERMEDADES INFECCIOSASP
Page 3 and 4:
Octubre 2011 INFECCIONES RELACIONAD
Page 5 and 6: Octubre 2011 INFECCIONES RELACIONAD
Page 55: Octubre 2011 INFECCIONES RELACIONAD
show all

Fichero a descargar de la publicaciÃ³n mostrada - Sociedad ...

Create successful ePaper yourself

Delete template?

Save as template?